Dale Vimalachandran retweeted
🎉 Congratulations @jim_tiernan & @jules_cornish on becoming @ACPGBI new Surgical Specialty Leads in Coloproctology
Together they'll innovate colorectal research with @RCSnews. A huge thank you to @susanmoug & @dalevim for their incredible service!
@BowelResearch
Dale Vimalachandran retweeted
Delighted to have won the
@RSMcoloproct
John of Arderne medal 🎖️ on my PhD researching metabolomic changes associated with radiation in locally advanced rectal cancer. Huge shout out to my supervisors @rickdunnblade @MSciacovelliLab & @dalevim for their support🚀🙏🧪😷!
Dale Vimalachandran retweeted
Global hospital-based disease management of acute #diverticulitis: a prospective, international cohort study
Reveals significant variation in the management and outcomes of patients presenting to hospital with acute diverticulitis
thelancet.com/journals/eclin…
Dale Vimalachandran retweeted
Enjoyed doing this with @JohnRTMonsonMD - A challenging but very enjoyable journey so far.
From being born with an absent right fibula to playing for England Universities at cricket, to being told I lack the intelligence to complete a higher degree to SSL for pancreatic surgery
#Surgeonslives is back! #stuffthatmatters We go to the UK and talk to @Drsampathak about #Surgery #Cricket #racism and #Charity Here is a clip but click on the link to watch the full interview youtu.be/f6qzhPfAqP8
@MCCOfficial @UniversityLeeds @asgbi @ALSGBandI
Dale Vimalachandran retweeted
linkedin.com/posts/cancer-re…
We're humbled to have been awarded a CRUK Programme Foundation Award to further progress our work on mutational order in cancer. New post-doctoral positions in our group to be advertised shortly. @NDSurgicalSci @OxfordCancer
Dale Vimalachandran retweeted
🚀 Got a Research Idea? Don’t Keep It to Yourself!
Get expert feedback on:
Design 🧩
PPI 💬
Funding 💷
Infrastructure 🏗️
Any topic. Any stage.
Small to large. Early to mature.
📥 Submit 250 words to [email protected] to book your slot
@hsekhar1982 @kjadams_surg
Dale Vimalachandran retweeted
We are appointing two new Colorectal Surgical Specialty Leads. Great to be continuing our partnership with @ACPGBI and @BowelResearch ! Deadline is 19 Sept - More info > tinyurl.com/colorectalssl @RCSnews
Dale Vimalachandran retweeted
Replying to @OCEaN_Trial
@OCEaN_Trial is now on the #bowelresapp - a joint venture between @BowelResearch and @ACPGBI. The app allows anyone to find out details of clinical trials in bowel disease and where the nearest centre taking part is.
@rachelcooney7 @dalevim
Dale Vimalachandran retweeted
Matt Lee gave a formidable @RCSnews Hunterian Lecture this morning @ACPGBI #acpgbi2025 on his work in small bowel obstruction @asgbi @Augishealth - really proud to present him with engraved medal in recognition of a decade’s work, & still ongoing
Dale Vimalachandran retweeted
Such an important piece of work 🙌 @GutsCharityUK @BowelResearch @LindAlliance A common but under researched (hard to believe) and therefore poorly understood condition! It was a privilege to be involved. Can’t wait to see what’s next ⬇️ @dalevim
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Dale Vimalachandran retweeted
Looking forward to hearing @C_Roxburgh present our PRIME RT trial results #ESTRO2025...exciting times in rectal radiation ! @UofGlasgow
📢 Don’t miss the Green Journal–Lancet Oncology joint plenary at #ESTRO2025!
🗓 Sun May 4 | ⏰ 11:40–12:45
📍 Plenary Hall
Top clinical trials in GI & SBRT from 🇬🇧 🇳🇱 🇨🇳 — including PLATO ACT 4, STAR-TREC, PRIME-RT & more.
#Radiotherapy #Oncology #GreenJournal
Dale Vimalachandran retweeted
LASER trial 4-year results @JAMASurgery!
Sigmoid resection vs conservative treatment for recurrent diverticulitis:
No difference in QOL or complications
Recurrences 16% vs 92%
BUT, 32% crossed conservative>surgery (pts w low QOL).
Interpretation🤔: Surgery for pts w low QOL
Dale Vimalachandran retweeted
MASSIVE Congratulations @lily_hillson PhD on navigating her viva with NO corrections @RadNetCRUKGla @UofGCancerSci 🎉👏🥂
‘Characterising dynamic tissue and immune response to RT in #rectalcancer’
Thanks Anna Wilkins @ICR_London and @s_milling for examining. Brilliant day!
Dale Vimalachandran retweeted
Delighted to be awarded the first @The_MRC / @GSK Clinician Scientist Fellowship as part of the innovative MRC Medicines Development Scheme led by @LivUni to use AI-driven drug discovery approaches to develop new treatments for inflammation induced lung injury and ARDS.
A Consultant Surgeon in Emergency General & Major Trauma at UHLG has been awarded a £2M Clinical Scientist award by the @The_MRC and GlaxoSmithKline 👏
This is part of a Development Fellowship scheme, supporting research into emergency medicine.
More: bit.ly/40rBADJ
Dale Vimalachandran retweeted
🚨Become an @RCSnews Surgical Specialty Lead! We're partnering again with @Augishealth to appoint 3 new SSLs in Pancreatic Cancer, CLM and Oesophageal Cancer (in partnership with @HeartburnCancer) - Deadline 24Jan - shorturl.at/e8Z2W
Dale Vimalachandran retweeted
Our clinical PhD programme, focussed on surgeons-in-training, is central to our research strategy and the future of surgery in the UK, EU, and rest of the world.
We take quality over quantity, give a hands on approach, and build future research leaders. We're advertising for 2 new posts to start October 2025, to start tackling:
-the intersection of technology and greener healthcare
-addressing data driven knowledge gaps to impact on how governments view surgery
-generating data and evidence syntheses to impact on pandemic preparedness in surgery
-strengthening supply chains around the world, for both environment sustainability and the delivery of minimally invasive surgery in the Global South
-reducing deaths after major surgery
-trends analysis in surgery
edzz.fa.em3.oraclecloud.com/…
Dale Vimalachandran retweeted
We are thrilled to welcome Natalie Blencowe and Matt Lee as our new Surgical Specialty Leads (SSL) in Emergency General Surgery (EGS).
Funded in collaboration with the NIHR HealthTech Research Centre in Accelerated Surgical Care, Natalie and Matt will work alongside the RCSEngland network, spearheading clinical trials and building networks to advance EGS practices across the UK.
Congratulations both!





























